If so, this genotype may emerge as a determinant contributing to the recently described phenotype of non-suppressed glucagon release upon glucose challenge, a phenotype that was associated with lower body weight and liver fat content, higher insulin sensitivity, and a reduced risk of glucose intolerance [15]. This evidence concerns the gene GCG and Glucose intolerance.